Surgical Management of Stone Disease in Patients With Primary Hyperoxaluria - 01/03/15
Abstract |
Objective |
To present our experience with surgical management of nephrolithiasis in patients with primary hyperoxaluria (PH).
Methods |
A retrospective chart review from 1994 to 2012 was performed to identify patients with diagnosis of PH.
Results |
A total of 14 patients with PH were identified with a median follow-up of 18.6 years (range, 0.9-51 years). Median ages at initial symptom and subsequent diagnosis were 6.7 years (range, 1.1-35.5 years) and 0.42 years (range, 0-33.25 years), respectively. Patients underwent a total of 54 procedures at our institution, including ureteroscopy (27 [50%]), percutaneous nephrolithotomy (15 [28%]), shock wave lithotripsy (8 [15%]), and combined procedures (4 [7%]). Overall nonintraparenchymal stone-free rate after the first, second, and third procedures were 59%, 76%, and 78%, respectively. On average, 1.6 procedures (range, 1-4) were required to rid patients of symptomatic stones, which subsequently afforded them a mean of 3.62 years (range, 0.25-21.5 years) without the need for additional intervention. There were 6 Clavien grade ≥III complications in 4 patients, including immediate postoperative end-stage renal disease in 3 patients.
Conclusion |
Despite optimal medical and surgical management, patients experience recurrent acute stone events requiring multiple urologic interventions. Significant complications such as end-stage renal disease can occur secondary to surgical intervention.
Le texte complet de cet article est disponible en PDF.Plan
Financial Disclosure: The authors declare that they have no relevant financial interests. |
|
Funding Support: This study was supported by the Rare Kidney Stone Consortium (U54KD083908), a member of the NIH Rare Disease Clinic Research Network (RDCRN), funded by the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) and the National Center for Advancing Translational Sciences (NCATS). Additional support has been provided by The Oxalosis and Hyperoxaluria Foundation. |
Vol 85 - N° 3
P. 522-526 - mars 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?